Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Palo Alto, CA
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Gainesville, FL
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
University of Florida Shands Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Downers Grove, IL
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Midwestern U Chicago College of Optometry
mi
from
Downers Grove, IL
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Indianapolis, IN
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Minneapolis, MN
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
U of MO St. Louis College of Optometry
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Durham, NC
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Duke University Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Akron, OH
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Akron Children's Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Oklahoma City, OK
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Dean A. McGee Eye Institute, University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital - Dept. Of Ophthalmology
mi
from
Houston, TX
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Lubbock, TX
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Texas Tech Univ. Hlth Sci. Ctr.
mi
from
Lubbock, TX
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
La Crosse, WI
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Gundersen Health System
mi
from
La Crosse, WI
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated:  12/31/1969
mi
from
Calgary,
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®: Clinical Comparison in a Symptomatic Population
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Worth, TX
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®: Clinical Comparison in a Symptomatic Population
Status: Enrolling
Updated: 12/31/1969
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
mi
from
Mountain View, CA
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Associates Medical Group Inc
mi
from
Mountain View, CA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
mi
from
The Woodlands, TX
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated:  12/31/1969
mi
from
Andover, MA
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Andover, MA
Click here to add this to my saved trials
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated:  12/31/1969
mi
from
Memphis, TN
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Optimal Method for Mydriasis in Cataract Surgery
Optimal Method for Mydriasis in Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
Optimal Method for Mydriasis in Cataract Surgery
Optimal Method for Mydriasis in Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Wilmer Eye Institute at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Worth, TX
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Status: Enrolling
Updated: 12/31/1969
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
A Pilot Study of Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
A Pilot Study of Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Mountain View, CA
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates Medical Group, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Marietta, GA
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Marietta Eye Clinic
mi
from
Marietta, GA
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Ayer, MA
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Fargo, ND
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Bergstrom Eye Research
mi
from
Fargo, ND
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Portland, OR
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University, Casey Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Pittsburgh, PA
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center Eye Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
The Woodlands, TX
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Lauderdale, FL
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Beltola Guwahati,
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Sri Sankaradeva Nethralaya
mi
from
Beltola Guwahati,
Click here to add this to my saved trials
Cataract Refractive Suite Study
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated:  12/31/1969
mi
from
Panama City, FL
Cataract Refractive Suite Study
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Alcon Investigative Site
mi
from
Panama City, FL
Click here to add this to my saved trials
Cataract Refractive Suite Study
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated:  12/31/1969
mi
from
Stillwater, MN
Cataract Refractive Suite Study
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Alcon Investigative Site
mi
from
Stillwater, MN
Click here to add this to my saved trials
Cataract Refractive Suite Study
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated:  12/31/1969
mi
from
Hurst, TX
Cataract Refractive Suite Study
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Alcon Investigative Site
mi
from
Hurst, TX
Click here to add this to my saved trials
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Status: Enrolling
Updated:  12/31/1969
mi
from
Birmingham, AL
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated:  12/31/1969
mi
from
Denver, CO
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver Eye Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
El Paso, TX
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
El Paso Eye Surgeons
mi
from
El Paso, TX
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Worth, TX
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Ophthalmology Associates
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
Fayetteville, AR
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Vold Vision, PLLC
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
Orange, CA
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Coastal Vision Medical Group
mi
from
Orange, CA
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
Oklahoma City, OK
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Dean McGee Eye Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Wills Eye Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye
An 8-week, Phase II, Single-center, Randomized, Double-masked, Vehicle-controlled, Parallel-group Study With 4 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Patients With Dry Eye
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye
An 8-week, Phase II, Single-center, Randomized, Double-masked, Vehicle-controlled, Parallel-group Study With 4 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Patients With Dry Eye
Status: Enrolling
Updated: 12/31/1969
Penn Dry Eye and Ocular Surface Center,University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma
An 8 Week Phase Ib, Monocentric, Randomized, Double-masked, Parallel Groups, Study With a 24 Week Follow-up to Evaluate Safety and Potential Efficacy of a 180 μg/ml rhNGF Eye Drops Solution Vs Vehicle in Patients With Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
Palo Alto, CA
Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma
An 8 Week Phase Ib, Monocentric, Randomized, Double-masked, Parallel Groups, Study With a 24 Week Follow-up to Evaluate Safety and Potential Efficacy of a 180 μg/ml rhNGF Eye Drops Solution Vs Vehicle in Patients With Glaucoma
Status: Enrolling
Updated: 12/31/1969
Byers Eye Institute at Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
mi
from
Tucson, AZ
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates Southwest, PC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
mi
from
Bakersfield, CA
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
mi
from
Campbell, CA
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Diagnostic Center
mi
from
Campbell, CA
Click here to add this to my saved trials